Bolt Biotherapeutics (6LP0) Q2 2024 Earnings Report
DE:6LP0 Q2 2024 EPS Results
- Actual EPS
- -EUR 10.01
- Consensus EPS
- -EUR 7.83
- Beat/Miss
- Missed by -EUR 2.18
- One Year Ago EPS
- -EUR 8.58
DE:6LP0 Q2 2024 Revenue Results
- Actual Revenue
- EUR 1.14M
- Expected Revenue
- EUR 898.58K
- Beat/Miss
- Beat by +EUR 241.41K
- YoY Revenue Growth
- -11.03%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 08/13/2024
- Time
- After Close
- Conference Call
- Tuesday, August 13, 2024
DE:6LP0 Upcoming Earnings
Bolt Biotherapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:6LP0 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 05, 2026 | 2026 (Q3) | -3.29- | -3.33 | ― | ― |
| Aug 11, 2026 | 2026 (Q2) | -3.03-4.09 | -3.99 | -2.47% (-0.10) | |
| May 12, 2026 | 2026 (Q1) | -2.55-3.85 | -5.19 | 25.69% (+1.33) | |
| Mar 12, 2026 | 2025 (Q4) | -5.46-3.43 | -7.51 | 54.29% (+4.08) | |
| Nov 12, 2025 | 2025 (Q3) | -5.07-3.33 | -7.15 | 53.50% (+3.83) | |
| Aug 14, 2025 | 2025 (Q2) | -5.63-3.99 | -10.01 | 60.18% (+6.03) | |
| May 12, 2025 | 2025 (Q1) | -6.35-5.19 | -5.01 | -3.57% (-0.18) | |
| Mar 24, 2025 | 2024 (Q4) | -6.80-7.51 | -8.4 | 10.64% (+0.89) | |
| Nov 12, 2024 | 2024 (Q3) | -6.08-7.15 | -7.69 | 6.98% (+0.54) | |
| Aug 13, 2024 | 2024 (Q2) | -7.83-10.01 | -8.58 | -16.67% (-1.43) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
